| ISSN |
1948-5190 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Harmeet Singh Mashiana, Amaninder Singh Dhaliwal, Harlan Sayles, Banreet Dhindsa, Ji Won Yoo, Qing Wu, Shailender Singh, Ali Siddiqui, Gordon Ohning, Mohit Girotra and Douglas G Adler |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Douglas G Adler, FACG, FASGE, MD, Professor, Division of Gastroenterology and Hepatology, University of Utah School of Medicine, Huntsman Cancer Center, 30 N 1900 E, Room 4R118, Salt Lake City, UT 84132, United States. douglas.adler@hsc.utah.edu |
| Key Words |
Meta-analysis; endoscopic retrograde cholangiopancreatography; Systematic review; Adverse events; Cirrhosis |
| Core Tip |
Patients with cirrhosis undergoing endoscopic retrograde cholangiopancreatography (ERCP) are considered to have increased risk. However, there is a paucity of literature describing the indications and outcomes of ERCP procedures in these patients. Our meta-analysis included 6,505 patients from 15 studies, with indications including choledocholithiasis, biliary strictures, gallstone pancreatitis and cholangitis. Types of interventions included sphincterotomy, stenting and dilation. Individual adverse events included hemorrhage, post-ERCP pancreatitis (PEP), and cholangitis. Comparison of ERCP-related complications in cirrhosis vs non-cirrhosis suggested higher overall rates of complications in cirrhosis patients with pooled (especially hemorrhage and PEP) but similar cholangitis rates. |
| Publish Date |
2018-11-16 06:28 |
| Citation |
Mashiana HS, Dhaliwal AS, Sayles H, Dhindsa B, Yoo JW, Wu Q, Singh S, Siddiqui AA, Ohning G, Girotra M, Adler DG. Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events. World J Gastrointest Endosc 2018; 10(11): 354-366 |
| URL |
http://www.wjgnet.com/1948-5190/full/v10/i11/354.htm |
| DOI |
http://dx.doi.org/10.4253/wjge.v10.i11.354 |
